Overall population:TP53: 68%KRAS: 80%PIK3CA: 90%Metastatic site vs. Primary tumor:TP53: 78% vs. 65%KRAS: 100% vs. 74%PIK3CA: 100% vs. 87%. Here, KRAS is linked to neoplasm.